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Data from the World Health Organization (National Institute on Aging, 2011) and the
National Institutes of Health (He et al., 2016) predicts that while today the worldwide
population over 65 years of age is estimated around 8.5%, this number will reach
an astounding 17% by 2050. In this framework, solving current neurodegenerative
diseases primarily associated with aging becomes more pressing than ever. In 2017, we
celebrate a grim 200th anniversary since the very first description of Parkinson’s disease
(PD) and its related symptomatology. Two centuries after this debilitating disease was
first identified, finding a cure remains a hopeful goal rather than an attainable objective
on the horizon. Tireless work has provided insight into the characterization and
progression of the disease down to a molecular level. We now know that the main
motor deficits associated with PD arise from the almost total loss of dopaminergic cells
in the substantia nigra pars compacta. A concomitant loss of cholinergic cells entails
a cognitive decline in these patients, and current therapies are only partially effective,
often inducing side-effects after a prolonged treatment. This review covers some of
the recent developments in the field of Basal Ganglia (BG) function in physiology and
pathology, with a particular focus on the two main neuromodulatory systems known to
be severely affected in PD, highlighting some of the remaining open question from three
main stand points:
- Heterogeneity of midbrain dopamine neurons.
- Pairing of dopamine (DA) sub-circuits.
- Dopamine-Acetylcholine (ACh) interaction.
A vast amount of knowledge has been accumulated over the years from experimental
conditions, but very little of it is reflected or used at a translational or clinical level. An
initiative to implement the knowledge that is emerging from circuit-based approaches
to tackle neurodegenerative disorders like PD will certainly be tremendously beneficial.
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INTRODUCTION
The Basal Ganglia (BG) are a group of nuclei comprising the striatum, the Globus pallidus
(internal—GPi and external—GPe segments), the subthalamic nucleus (STN) and the substantia
nigra (pars reticulata—SNr and pars compacta—SNc; Figure 1A). Together, these subcortical
areas process sensorimotor information to allow proper movement generation, including action
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FIGURE 1 | Recent developments in Basal Ganglia (BG) circuit organization. This figure aims at highlighting the increased knowledge collected in the last years in the
network organization of the BG with the Delong model proposed in the late 90’s as a starting point. (A) Schematic representing the Delong rate model of BG
organization where activation of the direct (full line) and indirect (dotted line) pathways has opposing effects onto the thalamo-cortical loop. In the direct pathway,
dMSNs inhibit the output structures (SNr/GPi), sending a GO motor signal; conversely the iMSNs disinhibit the subthalamic nucleus (STN) via the inhibition of the
GPe, ultimately providing a NO GO motor signal. (B) Simplified representation of the connectivity between BG nuclei, showing some of the recently described
synaptic contacts (reported in the current review as examples of the advances made in the field), as revealed by monosynaptic rabies anatomical mapping and/or
optogenetic and electrophysiological dissection. Green and red connection lines represent the direct inputs and outputs to SNc and VTA, highlighting the parallel
between motor and motivation/reward related circuits, respectively. DS, Dorsal striatum; NAc, nucleus accumbens; dMSN, direct pathway medium size spiny
neurons; iMSN, indirect pathway medium size spiny neurons; GPe, Globus Pallidus external; GPi, Globus Pallidus internal segment; STN, subthalamic nucleus; SNr,
Substantia Nigra pars Reticulata; SNc Substantia Nigra pars Compacta; mPFC, medial prefrontal cortex; M1, primary motor cortex; LH, lateral hypothalamus; PF,
parafascicular thalamus; RT, reticular thalamus; VL, ventro-lateral thalamus; LDT, latero-dorsal thalamus; LHb, lateral habenula; DR, dorsal raphe; PPN,
Pedunculopontine Nucleus; VTA, ventral tegmental area.
selection, planning, execution and orientation of locomotion
(Albin et al., 1989). Beyond its well acknowledged role in motor
function, recent studies have demonstrated the BG implication
in motivated behavior (Kravitz and Kreitzer, 2012; Kravitz et al.,
2012) which has been for a long time, attributed exclusively to
the reward system. The importance of adequate BG function is
highlighted in clinical evidence from BG related pathologies such
as Parkinson’s disease (PD), where SNc dopamine (DA) neurons
degenerate (Hornykiewicz, 1975a,b), leading to a multitude of
incapacitating symptoms ranging from motor dysfunctions to
cognitive disabilities (Lang and Lozano, 1998).
The main theory describing the anatomical organization of
BG nuclei or the so-called rate model (DeLong, 1990) is based
on a series of clinical observations diagnosing specific brain
lesions, experimental and post mortem human anatomy as well
as neurochemical analyses. This model describes two parallel
circuits, the direct and indirect pathways, both being modulated
by SNc DA. Activation of the direct pathway is motor-permissive
(GO), conversely, activation of the indirect pathway has motor-
suppressive (NOGO) effects (Figure 1A). This anatomical model
is supported at the molecular level by the well described DA
neuromodulation and signaling cascades involved, particularly
the opposing effects of DA onto direct and indirect medium
size spiny neurons (MSNs; dMSNs, iMSNs; respectively). For an
in-depth description of the BG anatomy we suggest the following
reviews (Alexander et al., 1986; Albin et al., 1989; DeLong,
1990).
Latest Anatomical Observations
The emergence of novel tools like circuit-based optogenetic
manipulations, in vivo single cell calcium imaging and
monosynaptic retrograde mapping (Boyden et al., 2005;
Watabe-Uchida et al., 2012; Cui et al., 2013) that allow the
probing of behavioral functions with a much higher degree
of specificity (Emiliani et al., 2015; Whissell et al., 2016), has
yielded in the past decade, a number of observations that on one
hand confirmed the principle of the GO vs. NO-GO hypothesis
(Kravitz et al., 2010) but also further depict the complexity
of the BG function and organization, ultimately augmenting
the original rate model. Without going into the details of all
the recent advances in the BG field, here we provide a few
representative examples (Figure 1B).
A very recent single cell transcriptional study has revealed
the existence of unreported pathways, namely entopenduncular
parvalbumin (EP-PV) cells projecting to the lateral habenula
(LHb) and the motor thalamus whereas EP-SOM (somatostatin)
cells projecting exclusively to the LHb (Wallace et al.,
2017).
Several routes of cortical information flow via indirect
pathways have now been identified. In addition to the inhibition
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of the STN (Mallet et al., 2012), the GPe also has inhibitory
control over the GPi (Smith et al., 1998), the reticular thalamic
nucleus (RT; Smith et al., 1998) and directly the SNr (Saunders
et al., 2016).
There is evidence of a high degree of reciprocal connectivity
between indirect pathway BG nuclei (GPe, STN, GPi, SN; Smith
et al., 1998; Mallet et al., 2012; Saunders et al., 2016) some
of which provide direct feedback outputs to cortical regions
(Saunders et al., 2015). The identification of synaptic connectivity
between two brain nuclei however, does not necessarily lead to
trivial consequences at the functional level. This is very well
exemplified by the lack of synchronous firing of the GPe and the
STN despite their robust connectivity (Baufreton et al., 2009).
These novel connections should therefore be also functionally
probed.
In relation with the activity of direct and indirect pathways,
several studies have identified the presence of lateral inhibitory
projections, particularly showing how there is not only D1-D1
and D2-D2 inhibition, but also reciprocal inhibition with the
indirect onto direct (D2-D1) being much stronger (Taverna
et al., 2008). These reciprocal connections are also differentially
modulated by DA itself (Tecuapetla et al., 2009). An interesting
yet undetermined aspect regarding these observations is the
importance of these mutual inhibitory connections for proper
motor behavior. Whether a further level of DA modulation at
these sites, going beyond the canonical striatal DA modulation
is necessary and to what extent, and if the loss of such
modulation would lead to motor impairments is still unexplored
territory.
Latest Behavioral Observations
In addition to pure anatomical progress, there has also been a
correlative increase in the knowledge at the functional level. Only
few studies combine the investigation of anatomical circuitry
and their impact on behavior. Lately a novel pathway linking
BG nuclei to non-BG nuclei has been described and reported
to process outcome evaluation. Specifically, habenular projecting
Globus Pallidus neurons integrate bidirectionally reward and
punishment expectation-related information (Stephenson-Jones
et al., 2016).
In vivo calcium imaging in awake behaving mice has
tremendously helped refining our knowledge. Action selection
relies on the fact that both direct and indirect pathways are
co-active and collaborate, with one promoting an action while
the other one suppresses competing actions (Fan et al., 2012; Cui
et al., 2013; Freeze et al., 2013; Isomura et al., 2013; Jin et al., 2014;
Tecuapetla et al., 2016).
Additional evidence regarding the behavioral function of
the BG has emerged from the pathology domain. Some
clinical observations support the rate model yet others highlight
its limitations. For example, STN deep brain stimulation
improves motor behavior in PD patients (Fasano et al.,
2012), and GPi unilateral pallidotomy improves cardinal
motor signs, including tremor, rigidity, bradykinesia (Vitek
et al., 2003), reason why both nuclei are thought to be
hyperactive in PD. Apomorphine (non-selective DA receptors
agonist) however, decreases the firing rate of the GPi but
not the STN (Bergman et al., 1990; Aziz et al., 1991; Lang
et al., 1997; Levy et al., 2001), despite the presence of DA
receptors in both regions (Sun et al., 2012; Galvan et al.,
2014). Alternative and yet to be characterized mechanisms
must therefore be involved, that allow a BG modulation of
motor function at a higher-level bypassing direct molecular
interactions.
We believe that a better knowledge of the circuitry and
its dynamics in physiological and the direct comparison to
pathological conditions will provide hints to understand the
reported discrepancies but most of all help with the design of
better targeted treatments. Although there are several debilitating
BG-related diseases, here we will only take into account PD,
considering that the basic principles discussed would also apply
to other pathologies.
The cause of PD is still unknown but the loss of
neuromodulation correlates with motor and cognitive
symptoms. So far, extensive work has been dedicated to the
investigation of different aspects of the disease such as the Lewy
body lesions and alpha-synuclein aggregation (Schirinzi et al.,
2016), as well as genetic factors (Tanner and Aston, 2000).
We propose that yet another aspect could prove instrumental
in designing effective therapies, and that is a circuit-based
approach.
This review is not an exhaustive overview of literature, it
rather aims at highlighting some of the remaining open questions
about BG in physiology and pathology, with a focus on DA and
Acetylcholine (ACh) neuromodulation, following three main
stand points:
- Heterogeneity of midbrain DA neurons.
- Pairing of DA sub-circuits.
- Dopamine-ACh interaction.
Molecular Signaling of Dopamine and
Acetylcholine
DA and ACh are the two main neuromodulators fine tuning the
activity of BG nuclei. The most striking argument in support of a
critical role of DA and ACh in the BG comes from pathological
conditions. At the diagnostic time point of PD, at least 70%
of SNc DA neurons have degenerated, consequently, motor
dysfunctions manifest (Hornykiewicz, 1975b). Concomitantly,
and as demonstrated with post-mortem human brain histology,
choline acetyltransferase (ChAT) expressing neurons also
degenerate (Nakano and Hirano, 1984; Braak et al., 2004).
Both the cell death and the reduction in cholinergic markers
correlate strongly with a decline in cognitive abilities assessed
through performance tests in PD patients (Perry et al., 1985).
For this reason, current therapies target both the DA and ACh
modulatory systems. Rivastigmine, a cholinesterase inhibitor
has proven effective in ameliorating the cognitive dysfunction
(van Laar et al., 2010).
To understand how DA and ACh play such an important role
in the BG physiology and dynamics, a first approach has yielded
the molecular characterization of which receptors they activate
and what intracellular signaling cascades are engaged to impact
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FIGURE 2 | Neuromodulation of MSNs. Schematic representing the
convergence of dopamine (DA) and ACh modulation on excitatory inputs onto
a dMSN in the dorsal striatum (DS). DA terminals modulate excitatory
neurotransmission forming synapses onto the neck of MSN spines; through
two molecular mechanisms involving DA and the co-released GABA. These
DAergic input is modulated by presynaptic nAChRs and this cholinergic
control can itself be fine-tuned via the presence of presynaptic D2Rs.
Activation of D1Rs, that are coupled to the Gαs protein, leads to the
production of cyclic adenosine monophosphate (cAMP) via the adenylate
cyclase (AC). This promotes the protein kinase A (PKA) function, which
phosphorylates DARPP32, indirectly driving an increase in neuronal excitability
via the activation of Ca2+ channels and NMDA receptors as well as the
inhibition of K+ channels.
neuronal activity (Figure 2). DA receptors are G-protein-coupled
receptors (GPCRs; Kebabian and Calne, 1979) that trigger two
opposing signaling cascades depending on the G-protein they
activate. The D1 and D5 receptors, members of the D1-like
family of DA receptors are coupled to Gsα/Golf, which activates
adenylyl cyclase (AC), increasing the intracellular concentration
of the second messenger cyclic adenosine monophosphate
(cAMP). Conversely D2, D3 andD4 receptors, part of the D2-like
family, are coupled to Giα, which inhibits the AC and therefore
blocks the production of cAMP (Surmeier et al., 2007). Elevated
levels of cAMP facilitate the activation of protein kinase A (PKA)
which in turn, among other targets, phosphorylates DARPP32
(Blank et al., 1997; commonly used as a biochemical marker to
identify MSNs; Fienberg et al., 1998), ERK and CREB, permitting
the transcription of immediate early genes (IEG) and also
phosphorylates NMDA receptor subunits (Hallett et al., 2006)
to allow Ca2+ influx and hence, increase neuronal excitability
(Carter and Sabatini, 2004). Lower levels of cAMP eventually
lead to reduced DARPP32 activation and IEG transcription and
decreased neuronal firing rate due to reduced Na+ currents
(Schiffmann et al., 1995) and an enhanced K+ conductance
(Pacheco-Cano et al., 1996). Through this molecular signaling
cascade, DA amplifies or reduces the strength of glutamatergic
synaptic drive coming from the Cortex/Thalamus, favoring the
activity of dMSNs and decreasing that of iMSNs (Nicola et al.,
2000).
ACh on the other hand, binds ionotropic or ligand gated
nicotinic (nACh) channels andmetabotropic muscarinic GPCRs.
Both types exhibit different isoforms with specific cellular and
sub-cellular locations. The nACh receptors are pentamers of
3α and 2β (3 and 9 neuronal isoforms, respectively) subunits.
The striatal receptors are composed of the α4, α6, α7 and β2,
β3 subunits (Wada et al., 1989). Those channels are mainly
expressed at presynaptic glutamatergic terminals and once
activated increase the Ca2+ and Na+ influxes contributing
to further depolarizing these terminals, enhancing the release
of neurotransmitters and neuromodulators. The muscarinic
receptors are classified into two groups the M1-like (M1,
M3 and M5) coupled to Gq and the M2-like (M2 and M4)
coupled to Gi/o. Post-synaptically, activation of the M1-like
receptors triggers the phospholipase C to increase the levels of
IP3 leading to the release of Ca2+ from internal stores, which
in turn can activate the transcription of various IEGs, and
eventually increase neuronal excitability (Narushima et al., 2007;
Kreitzer, 2009). Similarly, to the D2-like receptors, activation
of the M2-like receptors inhibits the AC signaling cascade
ultimately dampening neuronal excitability (Calabresi et al.,
1998).
The sub-cellular location of DA and ACh receptors is critical
to ensure fine and adequate tuning of the synaptic transmission
(Figure 2). For example, most MSNs are simultaneously
contacted by a dopaminergic and a glutamatergic input,
forming the so-called triad, where DA terminal fibers form
symmetric synapses on the neck of the dendritic spines whereas
glutamatergic afferents contact the head of the spine and form
asymmetric synapses (Smith et al., 1994). This triad architecture
is proposed to function as a hetero-synaptic coincidence detector
by which DA selectively influences the convergence of glutamate
at individual spines (Yao et al., 2008).
Heterogeneous Properties of Midbrain
Dopaminergic Cells
The DA neuronal population has revealed heterogeneous in
many aspects. The most striking evidence likely comes once
more from the clinical observation that motor manifestations
are primarily linked to the selective loss of DA neurons in the
SNc (Brichta and Greengard, 2014), whereas the very similar
DA neurons in the VTA demonstrate a higher degree of
resistance to degeneration (Dauer and Przedborski, 2003) and
don’t carry motor specific impairments. An intriguing question
is the extent of the difference between the SNc and the VTA
DA cells, and the underlying neurobiological substrates. It has
been proposed that the vulnerability to degeneration could lie
in the genetic or molecular profile of each cell group. Although
comparative analyses showed that only less than 3% of the
gene expression pattern is different (Grimm et al., 2004), a
number of studies reported potentially interesting differences.
Functional analysis showed more transcripts of metabolism,
mitochondrial machinery, lipid vesicle mediated transport and
kinase/phosphatase signaling in the SNc compared to VTA DA
neurons (Chung et al., 2005; Greene et al., 2010), whereas a
higher number of transcripts for proteins involved in synaptic
plasticity, cell survival and migration are found in the VTA
as compared to the SNc (Grimm et al., 2004). In terms of
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markers implicated in cell firing, an example of discrepancy is
the potassium channel GIRK2 protein and mRNA levels, being
less abundant in the VTA than in the SNc (Chung et al., 2005;
Eulitz et al., 2007; Fu et al., 2012). Conversely, the Calbindin
(CB) protein and mRNA levels are less abundant in SNc than
VTA (Chung et al., 2005; Greene et al., 2010). Furthermore, core
molecules that define a DA phenotype such as the dopamine
transporter (DAT) and vesicular monoamine transporter type-2
(VMAT2) show variability in their expression levels (Sanghera
et al., 1994; González-Hernández et al., 2004). Although it is not
clear which of the SNc or the VTA neurons express more of
these two markers due to discrepancies from different studies
(Liang et al., 2004; Reyes et al., 2013), it is acknowledged
that the levels are different. A thorough and comprehensive
characterization of the distribution of these markers would
provide a great tool for the investigation of midbrain DA
neurons.
Extensive work has shed light onto the differences in the
genomic and proteomic expression patterns of SNc and VTA
DA neurons (Brichta and Greengard, 2014; Veenvliet and Smidt,
2014; Anderegg et al., 2015), however only few studies have
correlated them with specific electrophysiological properties. CB
correlates with specific electrophysiological properties mediated
by hyperpolarization-activated cyclic nucleotide-gated (HCN)
channels (Neuhoff et al., 2002) and an inverse correlation was
reported with the probability of vesicle exocytosis (Pan and Ryan,
2012).
It is still not known if these differences are responsible for any
protective or harmful effects towards degeneration. As for any
other differences reported so far, we still lack enough compelling
evidence, for example, to understand whether the high CB
expression in VTA DA cells has a causal role in their resilience to
PD induced degeneration. In addition, no clear correlation has
been made to validate such proteins as early detection markers
for PD.
DA neuronal signaling has recently become even more
complex with the demonstration that some VTA cells have
the ability to co-release different neurotransmitters. It has
been reported that a subset of these neurons express tyrosine
hydroxylase (TH) and do not project to the ventral striatum (VS)
but to the LHb (Stamatakis et al., 2013). Furthermore, some VTA
DA neurons can co-release glutamate at the level of the VS. This
has been confirmed both in vitro (Sulzer et al., 1998; Joyce and
Rayport, 2000; Dal Bo et al., 2004; Stuber et al., 2010) and in vivo
(Chuhma et al., 2004; Hnasko et al., 2010).
Considering that DA can be released unaccompanied
or co-released with different neurotransmitters, the
functional/behavioral implication of each neurotransmission
modality is unknown. Similarly, GABA and glutamate neurons
projecting to DA innervated regions have been identified in
the VTA. The impact of the co-released GABA or glutamate vs.
their pure counterparts is also unanswered. Unless otherwise
proven developmental left-overs are a possibility and would
be responsible for the co-released forms. Another hypothesis
postulates that it provides the temporal specificity required for
reward prediction and/or incentive salience (Lapish et al.,
2006, 2007). Mice lacking vglut2 in DA neurons show
deficits in psychostimulant-induced locomotion, providing
some evidence that the ability of midbrain DA neurons to
co-release different neurotransmitters is crucial in some specific
cases at the behavioral level. Another hypothesis is that the
presence of main neurotransmitters in DA cells aids in the
vesicular packaging of DA itself, boosting the strength of DA
modulation (Hnasko et al., 2010; Wallén-Mackenzie et al.,
2010).
Molecular heterogeneity in the form of the specific channel
expression can lead to significant functional differences. Adult
SNc DA neurons rely on L-type voltage gated Ca2+ channels
Cav1.3 for pace making, whereas VTA DA neurons use voltage-
dependent Na+ channels (Chan et al., 2007). Further studies
have investigated differences within the VTA populations
converging anatomical, electrophysiological, and molecular
properties (Lammel et al., 2014; Anderegg et al., 2015). A subset
of DA cells exhibits unconventional fast-firing properties and
low DAT/TH and DAT/VMAT2 mRNA expression ratios, and
selectively projects to prefrontal cortex. These cells lack the
functional somatodendritic Girk2-coupled D2 autoreceptors. In
contrast, conventional slow-firing DA neurons only project to
the lateral shell of the nucleus accumbens (Nac), they express
higher DAT/TH and DAT/VMAT2 mRNA expression ratios as
well as D2 autoreceptors (Lammel et al., 2008).
The cells lacking the D2 autoreceptors were difficult to
classify, they are considered as DA insensitive DA neurons
(Margolis et al., 2006; Lammel et al., 2008). Even though
the controversy is still not clearly resolved, a recent study
using TH-GFP transgenic mice (eGFP under the control of
the TH promoter) may provide some clarifications (Krashia
et al., 2017). Combining electrophysiological recordings with
DA pharmacological application, it was shown that TH-GFP
positive cells exhibit different properties (cell body size, firing
frequency, Ih current, sensitivity to DA, cocaine and Met-
enkephalin). Such variability is correlated with the cell location
within a medio-lateral axis. For example, and more specifically;
the vast majority of SNc (98%) and VTA (92%) TH-GFP positive
cells are inhibited by DA, with VTA medial cells exhibiting
the lowest sensitivity. The latter population could identify with
the D2-lacking mesocortical subtype reported in Lammel et al.
(2008).
Another example of functional heterogeneity in VTA DA
neurons highlighted two subpopulations that while exhibiting
no hyperpolarizing currents (Ih), respond differentially to
rewarding vs. aversive stimuli. Medial shell projecting neurons
show an increased AMPA/NMDA ratio in response to cocaine,
whereas medial prefrontal cortex (mPFC) projecting cells go
through this adaptation but in response to an aversive stimulus
(hindpaw formalin injection). As a counterpart out of the Ih
positive cells, the lateral shell projecting neurons respond to both
types of stimuli, whereas nigrostriatal cells are insensitive to both
(Lammel et al., 2011).
From a circuit point of view, it was shown that the LDT-
VTA-Nac sub-circuit drives place preference, in contrast, the
Lhb-VTA-mPFC pathway produces place aversion highlighting
once more that neurons within the same midbrain population
can have strikingly different properties (Lammel et al., 2012).
Frontiers in Neural Circuits | www.frontiersin.org 5 December 2017 | Volume 11 | Article 110
Rizzi and Tan Neuromodulatory Circuitry in PD
The knowledge in DA heterogeneity has been much more
investigated in the VTA than in the SNc. However similar
concepts can be applied to the SNc DA neurons. Particularly,
SNc DA cell functional heterogeneity has been correlated with
differences in dendrite architecture and afferent connectivity
(Brown et al., 2009; Henny et al., 2012). Furthermore, K+-ATP
channels gate bursting activity selectively in medial SNc DA
neurons projecting to the dorsomedial striatum (DMS), but not
in lateral SNc DA neurons, which project to the dorsolateral
striatum (DLS; Schiemann et al., 2012).
Anatomical studies have reported input diversity with
GABAergic afferents arising from the striatum, the GP and
the SNr (Fujiyama et al., 2002; Boyes and Bolam, 2003), and
glutamatergic inputs from the STN and the pedunculopontine
nucleus (PPN; Bolam et al., 1991; Chatha et al., 2000). There
is also evidence that some SNc DA cells project to BG nuclei
other than the striatum (Smith and Kieval, 2000; Prensa and
Parent, 2001), for example the STN (Cragg et al., 2004).
Such heterogeneity in input and output connectivity could
imply that just as for the VTA, subsets of SNc DA cells are
embedded in different sub-circuits with specific and different
relevant roles for behavioral outcomes. Interestingly, during
goal-directed actions the DMS is more strongly recruited as
opposed to the DLS which is engaged to a lesser extend (Gremel
and Costa, 2013). It is tempting to speculate that the same
difference in coding properties could be observed at the level of
the SNc having subsets of cells recruited during goal-directed
vs. habitual actions that would project to DMS and DLS,
respectively.
SNc DA cells have also been shown to co-release GABA
resulting in the inhibition of dorsal striatal MSNs (Tritsch et al.,
2012, 2016). Oncemore the functional relevance and/or necessity
of such co-released GABA is unknown.
An additional level of complexity hinting towards diverse
functional roles of DA release encoded at different time scales has
been recently reported. Using complementary micro-dialysis and
voltametric methods during an adaptive-based decision-making
task, it was found that the motivational vigor of an action is
encoded within the tonic DA release in the time scale of minutes,
whereas acute DA released in the time scale of seconds assigns
the value to a reward (Hamid et al., 2016).
Understanding the heterogeneity within the SNcDAneuronal
population including their electrophysiogical properties, circuit
connectivity and hence behavioral specialization becomes
even more relevant and necessary when considering the PD
pathology. Placing all these observations of heterogeneous
properties in the pathological domain will provide crucial
information to identify markers/properties that determine the
faith of DA cells once the disease is ongoing, and would
provide opportunities for interventions with a diagnostic or
therapeutic goal.
Pairing of DA Sub-circuits
DA neurons in the VTA are thought to play important
roles in motivation and reward (Ikemoto, 2007) whereas SNc
DA neurons are important for sensorimotor function, motor
execution and habit formation (Haber, 2003). For an in depth
review of such functions, we suggest the following studies
Graybiel et al. (1994); Hikosaka et al. (1999); Yin and Knowlton
(2006).
In brief, pharmacological studies have shown that the
rewarding effects of many addictive drugs are mediated by DA
neurons localized in the VTA and projecting to the VS and limbic
cortices (i.e., the mesolimbic DA system; Koob, 1992; Robbins
and Everitt, 1996). This has been confirmed by optogenetic
studies showing that the excitation of VTA DA neurons induces
conditioned place preference in mice (Tsai et al., 2009), and
rodents are able to learn instrumental responding to excite VTA
DA neurons (Adamantidis et al., 2011;Witten et al., 2011; Pascoli
et al., 2015). The mesolimbic DA system also plays a role in
negative affect. Conditioned place aversion can be induced byDA
pharmacology (Shippenberg, 1991) and also with optogenetic
inhibition of VTA DA neurons (Stamatakis and Stuber, 2012;
Tan et al., 2012).
Once again, the value of SNc DA neurons is reflected by
motor dysfunction in PD as reported by DeLong (1990) and
the effectiveness of DA pharmacology as a treatment (Connolly
and Lang, 2014). In addition to motor deficits, PD patients
also suffer a cognitive decline (Wolters and Francot, 1998;
Duncan et al., 2014). Congruently, SNc DA cells are considered
to be key for focusing attention on significant and rewarding
stimuli, a requirement for the acquisition of new learned
behaviors (Schultz, 1986; Schultz et al., 1997; Wise, 2009). Recent
optogenetic studies have provided strong evidence supporting
this theory. Mice learn to self-stimulate SNc DA neurons (Rossi
et al., 2013) and it can be as rewarding as VTA DA photo-
activation (Ilango et al., 2014). Furthermore, photo-inhibition of
both cell types induces a similar aversion (Ilango et al., 2014).
This raises the question of the differential impact of SNc vs. VTA
DA neurons in modulating behavior, which is further supported
by studies reporting both populations acting as reward prediction
or teaching signals (Bromberg-Martin et al., 2010; Schultz, 2017;
Watabe-Uchida et al., 2017).
Any behavior is the sum of several components that are
integrated or synchronized in order to allow the behavior to be
generated adequately. This is also true for positive reinforcement
where in the simplest of cases, a motor and a reward component
play important roles. How is such integration happening?
In other words, how does DA from the SNc and from the
VTA collaborate to shape reinforcement? We hypothesize three
scenarios:
1. DA must be released by both cell types at the appropriate
targets within a very short time window to synchronize
the activity of the circuits responsible for the behavioral
sub-components. This would imply that the linking factor
is located upstream of the VTA and the SNc DA cells
(Figure 3A), and simultaneously recruits them. Anatomical
mapping approaches have revealed common inputs such
as the GP, DS, lateral hypothalamus (LH), dorsal raphe
(DR) or PPN (Watabe-Uchida et al., 2012). Recent studies
complement this approach by mapping monosynaptic inputs
to subpopulations of DA neurons that project to specific brain
areas (Beier et al., 2015; Lerner et al., 2015; Menegas et al.,
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FIGURE 3 | Pairing of functionally distinct dopaminergic sub-circuits. A salient external stimulus (blue arrow) can activate different pathways depending on the
context and valence of the stimulus. We propose 3 different scenarios speculating on how the BG circuitry can be engaged to produce an appropriate and complex
(reward and motor-based) behavioral response. (A) Upstream pairing scenario with a common input (e.g., GP) recruiting both VTA and SNc DA populations. When
such a common input is activated, it synchronizes the DA release of VTA and SNc at their specific targets (mPFC and DS, respectively), hence recruiting these
complementary pathways to engage both reward and motor programs for the execution of a task. (B) Local pairing via a so far unreported direct DA-DA interaction
where the activation of one DA neuronal population induces the modulation of the other, hence engaging both complementary output pathways (mPFC and DS) to
produce an elaborated behavioral outcome. (C) Downstream pairing scenario with mutual recruitment of output regions independently of the DA source. For
example, the activation of VTA DA cells engages its specific output target (the mPFC) which itself activates the SNc DA neurons’ target (DS) independently of the
release of DA from the SNc cells. Blue shading highlights the recruited regions for each scenario. Orange dotted shapes represent the location where the pairing
occurs.
2015). Even when DA-projection targets are specified, there
is still monosynaptic inputs to SNc and VTA from numerous
brain areas, some of which are overlapping (Ogawa et al.,
2014). Such an overlap at the input level, favors the hypothesis
that integration of VTA and SNc DA signal happens upstream
via these common regions. We speculate that when these
inputs are activated in response to external cues/stimuli, they
synchronize the release of SNc and VTA DA at different
targets, hence recruiting different yet specific pathways to
engage both motor and reward programs for the execution of
a reinforcement task.
2. Mutual local recruitment of VTA and SNc DA neurons would
provide a second alternative. It is possible that there is local
connectivity between midbrain DA cells and independently
from inputs and outputs the activation of one population
would induce the modulation of the other (Figure 3B),
although local synaptic connectivity between DA neurons
has not been experimentally demonstrated. Along this line of
thought, the co-released glutamate could act as an activator
of neighboring DA cells. Once a reward signal is processed
at the level of the VTA, it would then automatically recruit
the neighboring SNc motor component and vice versa. The
close proximity of the two structures and technical limitations
to study this hypothesis render this topic so far uncharted
territory. Paired recordings in vitro could help answering this
open question and provide the first evidence investigating
DA-DA interactions at the level of the midbrain. A follow
up step would need to characterize whether this DA-DA
interaction is crucial for the reward-motor pairing during
positive reinforcement learning.
3. A third possibility is that the synchronization of rewarding
and motor components of reinforcement happens
downstream of the SNc and VTA DA neurons (Figure 3C),
at the level of their functional output targets. In addition
to the expected motor effects, optogenetic self-stimulation
of dMSNs in the DMS leads to reinforcement of actions
while iMSNs self-stimulation triggers avoidance of actions
(Kravitz et al., 2012). This highlights how direct activation
of the postsynaptic targets of SNc is sufficient to produce
both motor and reward/avoidance phenotypes, supporting
the theory of local connectivity mechanisms that aid in
the synchronization of the two behavioral sub-components.
Furthermore, it was shown that the acquisition and expression
of the reinforcement was insensitive to DA pharmacology
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(Kravitz et al., 2012). These experimental observations
support a mechanism of action that recruits specific SNc and
VTA sub-circuits downstream and independently from the
release of DA.
Dopamine-Acetylcholine Interaction
SNc and VTA DA are crucial in all motor and reinforcement-
related behaviors. Without DA there is no learning. Once
more this notion is supported by a series of experimental and
clinical observations. In PD, cholinergic markers are significantly
reduced. Interestingly, ACh and DA share several characteristics
aside from suffering a decrease in PD. Both are critically involved
in learning processes, cholinergic interneurons (CINs) of the
striatum also undergo firing pattern changes during associative
learning as do midbrain DA neurons. Both neuromodulatory
systems interact at the level of the SNc, VTA and striatum, and
both cell types are able to co-release main neurotransmitters.
In the clinical field, six different stages correlating the
anatomical extent of the pathology with the development of
the symptoms (Braak et al., 2004) are used to describe the
progression of the disease. SNc DA degeneration has been
reported to occur only during stage 3, together with the loss of
cholinergic neurons in the nucleus basalis of Meynert (Nakano
and Hirano, 1984; Braak et al., 2004) and in the PPN (Hirsch
et al., 1987). In addition, there is evidence of a concurrent
reduction in cortical and striatal cholinergic markers. Both the
cell death and the reduction in cholinergic markers are strongly
correlated with a decline in cognitive function assessed by
memory tests in PD patients (Perry et al., 1985). To contrast
the cognitive dysfunction in PD, pharmacologically addressing
the loss of cholinergic neurons with a cholinesterase inhibitor
such as rivastigmine has proven effective (Emre et al., 2004).
Alternatively, counterbalancing the reduced DA influence on
striatal cells, by pharmacologically blocking cholinergic receptors
improves some motor symptoms such as tremor. Unfortunately,
cognitive side effects have been described, particularly affecting
learning and memory ability (Little et al., 1998) as well as
cognitive flexibility (Van Spaendonck et al., 1993). Such contrast
in the effects of ACh mediated therapies raises the possible
need of a reinterpretation of clinical data and nicotinic vs.
muscarinic receptors may end up being orthogonally affected
by these therapies. DA replacement therapy with the DA
precursor, L-DOPA, or with DA agonist has been shown to
increase the risk of developing cognitive symptoms following
a prolonged use (Alty et al., 2009; Brusa et al., 2013). This
intricate interaction between both neuromodulatory systems has
proven counterproductive for pharmacological therapies where
often the amelioration of certain aspects of the disease brings
undesired side effects. Better understanding this interaction at
a molecular and circuit level will help design novel and more
specific approaches that would avoid these undesired side effects.
Although there are other sources of ACh in the BG, we will
focus on the two most prominent and better characterized to
date, the striatum and the PPN.
Striatal ACh is supplied by an intrinsic neural network of
large-sized CINs. They comprise only 1%–2% of the striatal
cellular population (Kawaguchi, 1992, 1993). They display two
types of rhythmical discharges, tonic and bursting firing. In vivo
recording studies surprisingly revealed that CINs do not respond
to movement per se (Crutcher and DeLong, 1984a,b). They
exhibit a very special pattern of activity with a pause in firing
that is acquired in response to sensory stimuli that predict
motivationally significant outcomes (positive or negative). This
response is lost when this association is extinguished (Kimura
et al., 1984; Aosaki et al., 1994; Apicella et al., 1997; Apicella,
2002;Morris et al., 2004). The pause response is hence considered
a neural correlate of classical conditioning. DA neurons show
similar properties, they are first excited by a reward and if the
reward is preceded by an associated salient stimulus they respond
to the conditioned stimulus and not any more to the reward
itself (Schultz et al., 1997). The pause in the CINs’ tonic firing is
temporally correlated to the increase in firing of DAneurons. The
response of both neurons encodes the probability of reward: the
DA neurons respond to reward mismatch between expectation
and outcome, while the cholinergic pause represents the expected
timing of presentation reward (Fiorillo et al., 2003; Morris et al.,
2004).
The cholinergic response is quite homogeneous; however, it
can be preceded by brief increase in firing rate or followed by a
rebound excitation. Several studies have provided evidence for
intrinsic channel properties being responsible for this flanking
excitatory activity (Wilson and Goldberg, 2006). Some studies,
on the other hand, report the involvement of cortical (Reynolds
andWickens, 2004) or thalamic inputs in the generation of these
phases (Matsumoto et al., 2001). So far, no consensus has been
reached to determine whether this peculiar response is generated
purely due to intrinsic properties, is network derived, or if both
aspects are necessary, particularly for the learning ability the
pause represents.
CIN’s bursting and pause responses were shown to be
tightly synchronized population-wise (Raz et al., 1996) and
such features are crucial for learning mechanisms, specifically
for synaptic plasticity. In addition, ACh and DA interact
closely as evidenced by a very well cahracterized anatomical
and functional distribution. CINs express the D1 and D2-like
DA receptors (Wieland et al., 2014), conversely DA nerve
terminals express nACh receptors (Zoli et al., 2002; Figure 2).
Photostimulation of DA neurons was shown to drive regionally
heterogeneous synaptic responses in striatal CINs, including an
acute excitation followed by an inhibition in the Nac medial
shell (mediated by the co-released glutamate), a pause in the
Nac core and the dorsal striatum (DS; both DA dependent;
Chuhma et al., 2014). The pause response in the DS was also
reported to be partly mediated by GABA (Straub et al., 2014).
Conversely, the synchronized activation of CINs (electrical or
optical stimulation) and hence an increased ACh level has been
shown to induce the release of DA in the striatum as measured
by fast-scan cyclic voltammetry (Surmeier and Graybiel, 2012;
Threlfell et al., 2012). Such a synchronized CIN activation was
also reported to mediate the co-release of GABA from the DA
terminals to disynaptically inhibit MSNs (Nelson et al., 2014)
highlighting how the dopaminergic and cholinergic systems can
have a mutual modulation at the level of the striatum.
Frontiers in Neural Circuits | www.frontiersin.org 8 December 2017 | Volume 11 | Article 110
Rizzi and Tan Neuromodulatory Circuitry in PD
The acquisition of motor and cognitive action sequences
depends on this intra-striatal DA-ACh balance (Calabresi et al.,
2000). Through the interaction with DA, ACh has an integrative
and modulatory role in the BG circuitry (Kaneko et al., 2000).
During bursting, the increased level of ACh leads to M1 receptor
activation which induces long term potentiation (LTP), on the
opposite during the pause when ACh levels and M1 receptor
activation decreases, long term depression (LTD) is favored
(Centonze et al., 1999, 2003; Pisani et al., 2005; Bonsi et al.,
2011). Furthermore, the reduced level of ACh leads to a
diminished activation of nACh receptors on DA terminals,
ultimately disinhibiting DA release (Rice and Cragg, 2004; Zhang
and Sulzer, 2004; Cragg, 2006; Exley and Cragg, 2008). Hence,
the concomitant drop of ACh and increase of DA facilitates
D2 mediated LTD on MSNs. In this context, the pause response,
which is concurrent with increased firing of SNc DA cells
(Morris et al., 2004), may represent a period of enhanced LTD.
Since the pause increases as the association learned by classical
conditioning is strengthened (Aosaki et al., 1994), it has been
proposed as a mechanism to signal that the association is well
learnt, and so, the striatal network should refrain from engaging
in any other form of LTP which normally encodes initial phase
of learning.
Heterogeneity of CINs has not been reported to the extent
that it has for DA. To the best of our knowledge the
transcriptome and proteomic content of CINs have not been
thoroughly investigated. At the functional level, although the
pause pattern has been observed in response to both a reward
and a punishment, single CINs seem to be able to encode both
rewarding and aversive stimuli (Apicella, 2002).
Another source of ACh, able to modulate BG function has
been described, the PPN. This brain region holds cholinergic
projecting neurons that in contrast to the striatal CINs,
co-release glutamate or GABA. Furthermore, cholinergic PPN
neurons modulate DA cells and hence represent another
point of DA-ACh interaction. SNc DA cells represent an
important output target of PPN ACh neurons (Woolf and
Butcher, 1986; Beninato and Spencer, 1987, 1988). A certain
degree of heterogeneity has been reported; specifically, the
projection onto the lateral SNc DA neurons is mainly excitatory
(nicotinic or glutamatergic) and promotes locomotion whereas
the medial SNc DA neurons receive mostly cholinergic mediated
GABAergic transmission, which inhibits motor activity (Estakhr
et al., 2017).
The PPN was also reported as a monosynaptic input of
VTA DA neurons in mapping studies (Henderson and Sherriff,
1991; Watabe-Uchida et al., 2012), in fact, ascending ACh PPN
projections target DA neurons in the SNc and VTA following a
topographical gradient (Mena-Segovia et al., 2008). Optogenetic
release of ACh from the PPN was shown to increase the bursting
activity of VTA DA neurons. This connection is excitatory and
sufficient to increase motor activity (Dautan et al., 2016). The
potential involvement of ACh PPN modulation of SNc and VTA
DA neurons in reinforcing behavior remains unclear.
ACh PPN neurons also project to the striatum and the
synapses formed by the local vs. projecting ACh neurons can
be morphologically differentiated (Dautan et al., 2014). The
distinct activity of striatal CINs and brainstem ACh projecting-
cells during reward-related paradigms may suggest that the
two systems play different but complementary roles in the
processing of information in the striatum. Towards this line
of thought, it was suggested that the release of ACh from
CINs is tonic and interrupted by behaviorally relevant events,
whereas the release of ACh from the PPN would be phasically
increased during salient events (Dautan et al., 2014). The
functional relevance of the two distinct sources of ACh in
the striatum remains unresolved experimentally. The impact of
the co-release neurotransmitters glutamate and GABA is also
not clearly evaluated, and so far, PPN but not striatal CINs
have been shown to degenerate in PD, further highlighting
the differential role of these two sources of ACh, and the
importance of thoroughly characterizing them in an attempt to
find PD predictive markers or features that could be exploited in
therapeutic approaches.
The progression of PD related lesions, which was reported
to start in the lower brainstem and olfactory bulb, subsequently
moving up to the upper brainstem first invading the PPN
followed by the midbrain (Braak et al., 2004), represents
an important cue to follow. It is interesting to correlate
such sequence of degeneration with the circuit-connectivity
knowledge recently acquired, specifically PPN neurons
projecting to and modulating the midbrain. In other words,
even though the cause of the degeneration is still unknown, it is
tempting to hypothesize that the spreading of the disease follows
functional synaptic networks through mechanisms that still need
to be evaluated but might be similar to those described in protein
misfolding diseases (Pecho-Vrieseling et al., 2014).
CONCLUSION
Neuromodulation of the BG represents a critical aspect
in the generation of its different functions. Midbrain DA
neurons show a high level of heterogeneity when considering
biochemical markers, electrophysiological properties, co-release
of main neurotransmitters, input-output connectivity and
its related specialized behavioral functions. Such aspects
driving a functional heterogeneity, although not exhaustive,
raise the question of how the neurobiological substrates of
distinct behavioral sub-domains cooperate to generate complex
responses to environmental stimuli and ultimately maintain
homeostasis. Hence, acquiring more knowledge about the
neuromodulation of BG from the circuit/function point of
view is critical to better understand how BG functions are
generated in physiological conditions. For example, in vivo
calcium imaging of DA and ACh terminals arising from
functionally defined cell populations, in different projection
sites, within varied behavioral contexts would provide better
resolved information about the contribution of these two
neuromodulators to naturalistic actions. In a similar way,
site and function specific targeting of axons in a loss of
function experimental design would complement the previous
information and provide causal evidence of BG control of
actions. Once this information is available, it would be possible to
design medical approaches that can treat highly specific aspects
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of neurodegenerative disorders leaving all other functions intact.
For example, different strategies could be taken to treat the
motor symptoms of PD without carrying a cognitive decline and
vice versa.
In the last 15 years, the development of circuit dissection
tools and techniques have provided an incredible amount of
knowledge at a systems neuroscience level. Unfortunately, very
little of this information is reflected or used at the translational
or clinical domains. It will be a long road to accommodate
these new findings to refine the current pharmacological and
electrical treatments, but the modification of sub-circuits in PD
is an indispensable aspect that must be considered in the design
of optimally targeted therapies. A significant improvement in
therapeutical strategies may reside in the development of circuit
and cell type specific pharmacological compounds. As of today,
some pioneering studies are trying to address this challenge
combining site specific deep brain stimulation and pharmacology
(Creed et al., 2015).
AUTHOR CONTRIBUTIONS
Each author contributed equally to the design and writing of the
review.
FUNDING
This work has been funded by the Swiss National Science
foundation (PP00P3_150683, BSSGI0_155830).
REFERENCES
Adamantidis, A. R., Tsai, H.-C., Boutrel, B., Zhang, F., Stuber, G. D.,
Budygin, E. A., et al. (2011). Optogenetic interrogation of dopaminergic
modulation of the multiple phases of reward-seeking behavior. J. Neurosci. 31,
10829–10835. doi: 10.1523/JNEUROSCI.2246-11.2011
Albin, R., Young, A. B., and Penney, J. B. (1989). The functional anatomy
of basal ganglia disorders. Trends Neurosci. 12, 366–375. doi: 10.1016/0166-
2236(89)90074-X
Alexander, G. E., DeLong, M. R., and Strick, P. L. (1986). Parallel organization
of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev.
Neurosci. 9, 357–381. doi: 10.1146/annurev.neuro.9.1.357
Alty, J. E., Clissold, B. G., McColl, C. D., Reardon, K. A., Shiff, M.,
and Kempster, P. A. (2009). Longitudinal study of the levodopa motor
response in Parkinson’s disease: relationship between cognitive decline
and motor function. Mov. Disord. 24, 2337–2343. doi: 10.1002/mds.
22800
Anderegg, A., Poulin, J.-F., and Awatramani, R. (2015). Molecular heterogeneity of
midbrain dopaminergic neurons—Moving toward single cell resolution. FEBS
Lett. 589, 3714–3726. doi: 10.1016/j.febslet.2015.10.022
Aosaki, T., Tsubokawa, H., Ishida, A., Watanabe, K., Graybiel, A. M.,
and Kimura, M. (1994). Responses of tonically active neurons in the
primate’s striatum undergo systematic changes during behavioral sensorimotor
conditioning. J. Neurosci. 14, 3969–3984.
Apicella, P. (2002). Tonically active neurons in the primate striatum and their
role in the processing of information about motivationally relevant events. Eur.
J. Neurosci. 16, 2017–2026. doi: 10.1046/j.1460-9568.2002.02262.x
Apicella, P., Legallet, E., and Trouche, E. (1997). Responses of tonically discharging
neurons in the monkey striatum to primary rewards delivered during
different behavioral states. Exp. Brain Res. 116, 456–466. doi: 10.1007/pl000
05773
Aziz, T. Z., Peggs, D., Sambrook, M. A., and Crossman, A. R. (1991). Lesion
of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov.
Disord. 6, 288–292. doi: 10.1002/mds.870060404
Baufreton, J., Kirkham, E., Atherton, J. F., Menard, A., Magill, P. J., Bolam, J. P.,
et al. (2009). Sparse but selective and potent synaptic transmission from the
globus pallidus to the subthalamic nucleus. J. Neurophysiol. 102, 532–545.
doi: 10.1152/jn.00305.2009
Beier, K. T., Steinberg, E. E., DeLoach, K. E., Xie, S., Miyamichi, K., Schwarz, L.,
et al. (2015). Circuit architecture of VTA dopamine neurons revealed by
systematic input-output mapping. Cell 162, 622–634. doi: 10.1016/j.cell.2015.
07.015
Beninato, M., and Spencer, R. F. (1987). A cholinergic projection to the rat
substantia nigra from the pedunculopontine tegmental nucleus. Brain Res. 412,
169–174. doi: 10.1016/0006-8993(87)91455-7
Beninato, M., and Spencer, R. F. (1988). The cholinergic innervation of the rat
substantia nigra: a light and electron microscopic immunohistochemical study.
Exp. Brain Res. 72, 178–184. doi: 10.1007/bf00248513
Bergman, H., Wichmann, T., and DeLong, M. R. (1990). Reversal of experimental
parkinsonism by lesions of the subthalamic nucleus. Science 249, 1436–1438.
doi: 10.1126/science.2402638
Blank, T., Nijholt, I., Teichert, U., Kügler, H., Behrsing, H., Fienberg, A.,
et al. (1997). The phosphoprotein DARPP-32 mediates cAMP-dependent
potentiation of striatal N-methyl-D-aspartate responses. Proc. Natl. Acad. Sci.
U S A 94, 14859–14864. doi: 10.1073/pnas.94.26.14859
Bolam, J. P., Francis, C. M., and Henderson, Z. (1991). Cholinergic input to
dopaminergic neurons in the substantia nigra: a double immunocytochemical
study. Neuroscience 41, 483–494. doi: 10.1016/0306-4522(91)90343-m
Bonsi, P., Cuomo, D.,Martella, G.,Madeo, G., Schirinzi, T., Puglisi, F., et al. (2011).
Centrality of striatal cholinergic transmission in basal ganglia function. Front.
Neuroanat. 5:6. doi: 10.3389/fnana.2011.00006
Boyden, E. S., Zhang, F., Bamberg, E., Nagel, G., and Deisseroth, K. (2005).
Millisecond-timescale, genetically targeted optical control of neural activity.
Nat. Neurosci. 8, 1263–1268. doi: 10.1038/nn1525
Boyes, J., and Bolam, J. P. (2003). The subcellular localization of GABAB
receptor subunits in the rat substantia nigra. Eur. J. Neurosci. 18, 3279–3293.
doi: 10.1111/j.1460-9568.2003.03076.x
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., and Del Tredici, K. (2004).
Stages in the development of Parkinson’s disease-related pathology. Cell Tissue
Res. 318, 121–134. doi: 10.1007/s00441-004-0956-9
Brichta, L., and Greengard, P. (2014). Molecular determinants of selective
dopaminergic vulnerability in Parkinson’s disease: an update. Front.
Neuroanat. 8:152. doi: 10.3389/fnana.2014.00152
Bromberg-Martin, E. S., Matsumoto, M., and Hikosaka, O. (2010). Dopamine in
motivational control: rewarding, aversive, and alerting. Neuron 68, 815–834.
doi: 10.1016/j.neuron.2010.11.022
Brown, M. T. C., Henny, P., Bolam, J. P., and Magill, P. J. (2009). Activity
of neurochemically heterogeneous dopaminergic neurons in the substantia
nigra during spontaneous and driven changes in brain state. J. Neurosci. 29,
2915–2925. doi: 10.1523/JNEUROSCI.4423-08.2009
Brusa, L., Pavino, V., Massimetti, M. C., Bove, R., Iani, C., and Stanzione, P.
(2013). The effect of dopamine agonists on cognitive functions in
non-demented early-mild Parkinson’s disease patients. Funct. Neurol. 28,
13–17. doi: 10.11138/FNeur/2013.28.1.013
Calabresi, P., Centonze, D., and Bernardi, G. (2000). Cellular factors controlling
neuronal vulnerability in the brain: a lesson from the striatum. Neurology 55,
1249–1255. doi: 10.1212/WNL.55.9.1249
Calabresi, P., Centonze, D., Pisani, A., Sancesario, G., North, R. A.,
and Bernardi, G. (1998). Muscarinic IPSPs in rat striatal cholinergic
interneurones. J. Physiol. 510, 421–427. doi: 10.1111/j.1469-7793.1998.
421bk.x
Carter, A. G., and Sabatini, B. L. (2004). State-dependent calcium signaling
in dendritic spines of striatal medium spiny neurons. Neuron 44, 483–493.
doi: 10.1016/j.neuron.2004.10.013
Centonze, D., Grande, C., Saulle, E., Martin, A. B., Gubellini, P., Pavón, N., et al.
(2003). Distinct roles of D1 and D5 dopamine receptors in motor activity and
striatal synaptic plasticity. J. Neurosci. 23, 8506–8512.
Frontiers in Neural Circuits | www.frontiersin.org 10 December 2017 | Volume 11 | Article 110
Rizzi and Tan Neuromodulatory Circuitry in PD
Centonze, D., Gubellini, P., Bernardi, G., and Calabresi, P. (1999). Permissive role
of interneurons in corticostriatal synaptic plasticity. Brain Res. Rev. 31, 1–5.
doi: 10.1016/s0165-0173(99)00018-1
Chan, C. S., Guzman, J. N., Ilijic, E., Mercer, J. N., Rick, C., Tkatch, T., et al. (2007).
‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease.
Nature 447, 1081–1086. doi: 10.1038/nature05865
Chatha, B. T., Bernard, V., Streit, P., and Bolam, J. P. (2000). Synaptic localization
of ionotropic glutamate receptors in the rat substantia nigra. Neuroscience 101,
1037–1051. doi: 10.1016/s0306-4522(00)00432-2
Chuhma, N., Mingote, S., Moore, H., and Rayport, S. (2014). Dopamine neurons
control striatal cholinergic neurons via regionally heterogeneous dopamine and
glutamate signaling. Neuron 81, 901–912. doi: 10.1016/j.neuron.2013.12.027
Chuhma, N., Zhang, H., Masson, J., Zhuang, X., Sulzer, D., Hen, R., et al. (2004).
Dopamine neurons mediate a fast excitatory signal via their glutamatergic
synapses. J. Neurosci. 24, 972–981. doi: 10.1523/JNEUROSCI.4317-03.2004
Chung, C. Y., Seo, H., Sonntag, K. C., Brooks, A., Lin, L., and Isacson, O. (2005).
Cell type-specific gene expression of midbrain dopaminergic neurons reveals
molecules involved in their vulnerability and protection. Hum. Mol. Genet. 14,
1709–1725. doi: 10.1093/hmg/ddi178
Connolly, B. S., and Lang, A. E. (2014). Pharmacological treatment of Parkinson
disease: a review. JAMA 311, 1670–1683. doi: 10.1001/jama.2014.3654
Cragg, S. J. (2006). Meaningful silences: how dopamine listens to the ACh pause.
Trends Neurosci. 29, 125–131. doi: 10.1016/j.tins.2006.01.003
Cragg, S. J., Baufreton, J., Xue, Y., Bolam, J. P., and Bevan, M. D. (2004).
Synaptic release of dopamine in the subthalamic nucleus. Eur. J. Neurosci. 20,
1788–1802. doi: 10.1111/j.1460-9568.2004.03629.x
Creed, M., Pascoli, V. J., and Lüscher, C. (2015). Addiction therapy. Refining
deep brain stimulation to emulate optogenetic treatment of synaptic pathology.
Science 347, 659–664. doi: 10.1126/science.1260776
Crutcher, M. D., and DeLong, M. R. (1984a). Single cell studies of the
primate putamen. I. Functional organization. Exp. Brain Res. 53, 233–243.
doi: 10.1007/bf00238153
Crutcher, M. D., and DeLong, M. R. (1984b). Single cell studies of the primate
putamen. II. Relations to direction of movement and pattern of muscular
activity. Exp. Brain Res. 53, 244–258. doi: 10.1007/bf00238154
Cui, G., Jun, S. B., Jin, X., Pham, M. D., Vogel, S. S., Lovinger, D. M., et al. (2013).
Concurrent activation of striatal direct and indirect pathways during action
initiation. Nature 494, 238–242. doi: 10.1038/nature11846
Dal Bo, G., St-Gelais, F., Danik, M., Williams, S., Cotton, M., and Trudeau, L.-E.
(2004). Dopamine neurons in culture express VGLUT2 explaining their
capacity to release glutamate at synapses in addition to dopamine.
J. Neurochem. 88, 1398–1405. doi: 10.1046/j.1471-4159.2003.02277.x
Dauer, W., and Przedborski, S. (2003). Parkinson’s disease: mechanisms and
models. Neuron 39, 889–909. doi: 10.1016/S0896-6273(03)00568-3
Dautan, D., Huerta-Ocampo, I., Witten, I. B., Deisseroth, K., Bolam, J. P.,
Gerdjikov, T., et al. (2014). A major external source of cholinergic innervation
of the striatum and nucleus accumbens originates in the brainstem. J. Neurosci.
34, 4509–4518. doi: 10.1523/JNEUROSCI.5071-13.2014
Dautan, D., Souza, A. S., Huerta-Ocampo, I., Valencia, M., Assous, M.,
Witten, I. B., et al. (2016). Segregated cholinergic transmission modulates
dopamine neurons integrated in distinct functional circuits. Nat. Neurosci. 19,
1025–1033. doi: 10.1038/nn.4335
DeLong, M. R. (1990). Primate models of movement disorders of basal ganglia
origin. Trends Neurosci. 13, 281–285. doi: 10.1016/0166-2236(90)90110-v
Duncan, G. W., Khoo, T. K., Yarnall, A. J., O’Brien, J. T., Coleman, S. Y.,
Brooks, D. J., et al. (2014). Health-related quality of life in early Parkinson’s
disease: the impact of nonmotor symptoms. Mov. Disord. 29, 195–202.
doi: 10.1002/mds.25664
Emiliani, V., Cohen, A. E., Deisseroth, K., and Häusser, M. (2015). All-
optical interrogation of neural circuits. J. Neurosci. 35, 13917–13926.
doi: 10.1523/JNEUROSCI.2916-15.2015
Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., De Deyn, P. P., et al.
(2004). Rivastigmine for dementia associated with Parkinson’s disease.N. Engl.
J. Med. 351, 2509–2518. doi: 10.1056/NEJMoa041470
Estakhr, J., Abazari, D., Frisby, K., McIntosh, J. M., and Nashmi, R.
(2017). Differential control of dopaminergic excitability and locomotion by
cholinergic inputs in mouse substantia nigra. Curr. Biol. 27, 1900.e4–1914.e4.
doi: 10.1016/j.cub.2017.05.084
Eulitz, D., Prüss, H., Derst, C., and Veh, R. W. (2007). Heterogeneous
distribution of kir3 potassium channel proteins within dopaminergic neurons
in the mesencephalon of the rat brain. Cell. Mol. Neurobiol. 27, 285–302.
doi: 10.1007/s10571-006-9118-9
Exley, R., and Cragg, S. J. (2008). Presynaptic nicotinic receptors: a dynamic
and diverse cholinergic filter of striatal dopamine neurotransmission. Br.
J. Pharmacol. 153, S283–S297. doi: 10.1038/sj.bjp.0707510
Fan, K. Y., Baufreton, J., Surmeier, D. J., Chan, C. S., and Bevan, M. D.
(2012). Proliferation of external globus pallidus-subthalamic nucleus synapses
following degeneration of midbrain dopamine neurons. J. Neurosci. 32,
13718–13728. doi: 10.1523/JNEUROSCI.5750-11.2012
Fasano, A., Daniele, A., and Albanese, A. (2012). Treatment of motor and
non-motor features of Parkinson’s disease with deep brain stimulation. Lancet
Neurol. 11, 429–442. doi: 10.1016/s1474-4422(12)70049-2
Fienberg, A. A., Hiroi, N., Mermelstein, P. G., Song, W., Snyder, G. L., Nishi, A.,
et al. (1998). DARPP-32: regulator of the efficacy of dopaminergic
neurotransmission. Science 281, 838–842. doi: 10.1126/science.281.53
78.838
Fiorillo, C. D., Tobler, P. N., and Schultz, W. (2003). Discrete coding of reward
probability and uncertainty by dopamine neurons. Science 299, 1898–1902.
doi: 10.1126/science.1077349
Freeze, B. S., Kravitz, A. V., Hammack, N., Berke, J. D., and Kreitzer, A. C. (2013).
Control of basal ganglia output by direct and indirect pathway projection
neurons. J. Neurosci. 33, 18531–18539. doi: 10.1523/JNEUROSCI.1278-
13.2013
Fu, Y., Yuan, Y., Halliday, G., Rusznák, Z., Watson, C., and Paxinos, G. (2012). A
cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups
in the substantia nigra, ventral tegmental area and retrorubral field in the
mouse. Brain Struct. Funct. 217, 591–612. doi: 10.1007/s00429-011-0349-2
Fujiyama, F., Stephenson, F. A., and Bolam, J. P. (2002). Synaptic localization of
GABAA receptor subunits in the substantia nigra of the rat: effects of quinolinic
acid lesions of the striatum. Eur. J. Neurosci. 15, 1961–1975. doi: 10.1046/j.1460-
9568.2002.02017.x
Galvan, A., Hu, X., Rommelfanger, K. S., Pare, J.-F., Khan, Z. U., Smith, Y., et al.
(2014). Localization and function of dopamine receptors in the subthalamic
nucleus of normal and parkinsonian monkeys. J. Neurophysiol. 112, 467–479.
doi: 10.1152/jn.00849.2013
González-Hernández, T., Barroso-Chinea, P., De La Cruz Muros, I., Del Mar
Pérez-Delgado, M., and Rodríguez, M. (2004). Expression of dopamine and
vesicular monoamine transporters and differential vulnerability of mesostriatal
dopaminergic neurons. J. Comp. Neurol. 479, 198–215. doi: 10.1002/cne.20323
Graybiel, A. M., Aosaki, T., Flaherty, A. W., and Kimura, M. (1994).
The basal ganglia and adaptive motor control. Science 265, 1826–1831.
doi: 10.1126/science.8091209
Greene, J. G., Dingledine, R., and Greenamyre, J. T. (2010). Neuron-selective
changes in RNA transcripts related to energy metabolism in toxic models
of parkinsonism in rodents. Neurobiol. Dis. 38, 476–481. doi: 10.1016/j.nbd.
2010.03.014
Gremel, C. M., and Costa, R. M. (2013). Orbitofrontal and striatal circuits
dynamically encode the shift between goal-directed and habitual actions. Nat.
Commun. 4:2264. doi: 10.1038/ncomms3264
Grimm, J., Mueller, A., Hefti, F., and Rosenthal, A. (2004). Molecular basis
for catecholaminergic neuron diversity. Proc. Natl. Acad. Sci. U S A 101,
13891–13896. doi: 10.1073/pnas.0405340101
Haber, S. N. (2003). The primate basal ganglia: parallel and integrative networks.
J. Chem. Neuroanat. 26, 317–330. doi: 10.1016/j.jchemneu.2003.10.003
Hallett, P. J., Spoelgen, R., Hyman, B. T., Standaert, D. G., and Dunah, A. W.
(2006). Dopamine D1 activation potentiates striatal NMDA receptors by
tyrosine phosphorylation-dependent subunit trafficking. J. Neurosci. 26,
4690–4700. doi: 10.1523/JNEUROSCI.0792-06.2006
Hamid, A. A., Pettibone, J. R., Mabrouk, O. S., Hetrick, V. L., Schmidt, R., Vander
Weele, C. M., et al. (2016). Mesolimbic dopamine signals the value of work.
Nat. Neurosci. 19, 117–126. doi: 10.1038/nn.4173
He, W., Goodkind, D., and Kowal, P. (2016). An Aging World: 2015.Washington,
DC: U.S. Government Publishing Office.
Henderson, Z., and Sherriff, F. E. (1991). Distribution of choline acetyltransferase
immunoreactive axons and terminals in the rat and ferret brainstem. J. Comp.
Neurol. 314, 147–163. doi: 10.1002/cne.903140114
Frontiers in Neural Circuits | www.frontiersin.org 11 December 2017 | Volume 11 | Article 110
Rizzi and Tan Neuromodulatory Circuitry in PD
Henny, P., Brown, M. T. C., Northrop, A., Faunes, M., Ungless, M. A.,
Magill, P. J., et al. (2012). Structural correlates of heterogeneous in vivo activity
of midbrain dopaminergic neurons. Nat. Neurosci. 15, 613–619. doi: 10.1038/
nn.3048
Hikosaka, O., Nakahara, H., Rand, M. K., Sakai, K., Lu, X., Nakamura, K., et al.
(1999). Parallel neural networks for learning sequential procedures. Trends
Neurosci. 22, 464–471. doi: 10.1016/s0166-2236(99)01439-3
Hirsch, E. C., Graybiel, A. M., Duyckaerts, C., and Javoy-Agid, F. (1987). Neuronal
loss in the pedunculopontine tegmental nucleus in Parkinson disease and in
progressive supranuclear palsy. Proc. Natl. Acad. Sci. U S A 84, 5976–5980.
doi: 10.1073/pnas.84.16.5976
Hnasko, T. S., Chuhma, N., Zhang, H., Goh, G. Y., Sulzer, D., Palmiter, R. D.,
et al. (2010). Vesicular glutamate transport promotes dopamine storage and
glutamate corelease in vivo. Neuron 65, 643–656. doi: 10.1016/j.neuron.2010.
02.012
Hornykiewicz, O. (1975a). Brain monoamines and Parkinsonism.
Psychopharmacol. Bull. 11, 34–35.
Hornykiewicz, O. (1975b). Brain monoamines and Parkinsonism. Natl. Inst. Drug
Abuse Res. Monogr. Ser. 3, 13–21. doi: 10.1037/e472122004-001
Ikemoto, S. (2007). Dopamine reward circuitry: two projection systems from the
ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain
Res. Rev. 56, 27–78. doi: 10.1016/j.brainresrev.2007.05.004
Ilango, A., Kesner, A. J., Keller, K. L., Stuber, G. D., Bonci, A., and Ikemoto, S.
(2014). Similar roles of substantia nigra and ventral tegmental dopamine
neurons in reward and aversion. J. Neurosci. 34, 817–822. doi: 10.1523
/JNEUROSCI.1703-13.2014
Isomura, Y., Takekawa, T., Harukuni, R., Handa, T., Aizawa, H., Takada, M.,
et al. (2013). Reward-modulated motor information in identified striatum
neurons. J. Neurosci. 33, 10209–10220. doi: 10.1523/JNEUROSCI.0381-
13.2013
Jin, X., Tecuapetla, F., and Costa, R. M. (2014). Basal ganglia subcircuits
distinctively encode the parsing and concatenation of action sequences. Nat.
Neurosci. 17, 423–430. doi: 10.1038/nn.3632
Joyce, M. P., and Rayport, S. (2000). Mesoaccumbens dopamine neuron
synapses reconstructed in vitro are glutamatergic. Neuroscience 99, 445–456.
doi: 10.1016/s0306-4522(00)00219-0
Kaneko, S., Hikida, T., Watanabe, D., Ichinose, H., Nagatsu, T., Kreitman, R. J.,
et al. (2000). Synaptic integration mediated by striatal cholinergic interneurons
in basal ganglia function. Science 289, 633–637. doi: 10.1126/science.289.
5479.633
Kawaguchi, Y. (1992). Large aspiny cells in the matrix of the rat neostriatum
in vitro: physiological identification, relation to the compartments and
excitatory postsynaptic currents. J. Neurophysiol. 67, 1669–1682.
Kawaguchi, Y. (1993). Physiological, morphological, and histochemical
characterization of three classes of interneurons in rat neostriatum. J. Neurosci.
13, 4908–4923.
Kebabian, J. W., and Calne, D. B. (1979). Multiple receptors for dopamine. Nature
277, 93–96. doi: 10.1038/277093a0
Kimura, M., Rajkowski, J., and Evarts, E. (1984). Tonically discharging putamen
neurons exhibit set-dependent responses. Proc. Natl. Acad. Sci. U S A 81,
4998–5001. doi: 10.1073/pnas.81.15.4998
Koob, G. F. (1992). Drugs of abuse: anatomy, pharmacology and function of
reward pathways. Trends Pharmacol. Sci. 13, 177–184. doi: 10.1016/0165-
6147(92)90060-j
Krashia, P., Martini, A., Nobili, A., Aversa, D., D’Amelio, M., Berretta, N., et al.
(2017). On the properties of identified dopaminergic neurons in the mouse
substantia nigra and ventral tegmental area. Eur. J. Neurosci. 45, 92–105.
doi: 10.1111/ejn.13364
Kravitz, A. V., Freeze, B. S., Parker, P. R. L., Kay, K., Thwin, M. T., Deisseroth, K.,
et al. (2010). Regulation of parkinsonian motor behaviours by optogenetic
control of basal ganglia circuitry. Nature 466, 622–626. doi: 10.1038/natu
re09159
Kravitz, A. V., and Kreitzer, A. C. (2012). Striatal mechanisms underlying
movement, reinforcement, and punishment. Physiology 27, 167–177.
doi: 10.1152/physiol.00004.2012
Kravitz, A. V., Tye, L. D., and Kreitzer, A. C. (2012). Distinct roles for direct and
indirect pathway striatal neurons in reinforcement.Nat. Neurosci. 15, 816–818.
doi: 10.1038/nn.3100
Kreitzer, A. C. (2009). Physiology and pharmacology of striatal neurons. Annu.
Rev. Neurosci. 32, 127–147. doi: 10.1146/annurev.neuro.051508.135422
Lammel, S., Hetzel, A., Häckel, O., Jones, I., Liss, B., and Roeper, J. (2008). Unique
properties of mesoprefrontal neurons within a dual mesocorticolimbic
dopamine system. Neuron 57, 760–773. doi: 10.1016/j.neuron.2008.
01.022
Lammel, S., Ion, D. I., Roeper, J., and Malenka, R. C. (2011). Projection-specific
modulation of dopamine neuron synapses by aversive and rewarding stimuli.
Neuron 70, 855–862. doi: 10.1016/j.neuron.2011.03.025
Lammel, S., Lim, B. K., and Malenka, R. C. (2014). Reward and aversion in a
heterogeneous midbrain dopamine system. Neuropharmacology 76, 351–359.
doi: 10.1016/j.neuropharm.2013.03.019
Lammel, S., Lim, B. K., Ran, C., Huang, K. W., Betley, M. J., Tye, K. M., et al.
(2012). Input-specific control of reward and aversion in the ventral tegmental
area. Nature 491, 212–217. doi: 10.1038/nature11527
Lang, A. E., and Lozano, A. M. (1998). Parkinson’s disease. First of two parts. N.
Engl. J. Med. 339, 1044–1053. doi: 10.1056/NEJM199810083391506
Lang, A. E., Lozano, A. M., Montgomery, E., Duff, J., Tasker, R., and
Hutchinson, W. (1997). Posteroventral medial pallidotomy in advanced
Parkinson’s disease. N. Engl. J. Med. 337, 1036–1042. doi: 10.1056/NEJM1997
10093371503
Lapish, C. C., Kroener, S., Durstewitz, D., Lavin, A., and Seamans, J. K. (2007).
The ability of the mesocortical dopamine system to operate in distinct temporal
modes. Psychopharmacology 191, 609–625. doi: 10.1007/s00213-006-0527-8
Lapish, C. C., Seamans, J. K., and Chandler, L. J. (2006). Glutamate-dopamine
cotransmission and reward processing in addiction. Alcohol. Clin. Exp. Res. 30,
1451–1465. doi: 10.1111/j.1530-0277.2006.00176.x
Lerner, T. N., Shilyansky, C., Davidson, T. J., Evans, K. E., Beier, K. T.,
Zalocusky, K. A., et al. (2015). Intact-brain analyses reveal distinct information
carried by SNc dopamine subcircuits. Cell 162, 635–647. doi: 10.1016/j.cell.
2015.07.014
Levy, R., Dostrovsky, J. O., Lang, A. E., Sime, E., Hutchison, W. D., and
Lozano, A. M. (2001). Effects of apomorphine on subthalamic nucleus
and globus pallidus internus neurons in patients with Parkinson’s disease.
J. Neurophysiol. 86, 249–260. doi: 10.1152/jn.2001.86.1.249
Liang, C.-L., Nelson, O., Yazdani, U., Pasbakhsh, P., and German, D. C. (2004).
Inverse relationship between the contents of neuromelanin pigment and the
vesicular monoamine transporter-2: human midbrain dopamine neurons.
J. Comp. Neurol. 473, 97–106. doi: 10.1002/cne.20098
Little, J. T., Johnson, D. N., Minichiello, M., Weingartner, H., and
Sunderland, T. (1998). Combined nicotinic and muscarinic blockade
in elderly normal volunteers: cognitive, behavioral, and physiologic
responses. Neuropsychopharmacology 19, 60–69. doi: 10.1016/s0893-133x(98)
00002-5
Mallet, N., Micklem, B. R., Henny, P., Brown, M. T., Williams, C., Bolam, J. P.,
et al. (2012). Dichotomous organization of the external globus pallidus.Neuron
74, 1075–1086. doi: 10.1016/j.neuron.2012.04.027
Margolis, E. B., Lock, H., Hjelmstad, G. O., and Fields, H. L. (2006). The
ventral tegmental area revisited: is there an electrophysiological marker for
dopaminergic neurons? J. Physiol. 577, 907–924. doi: 10.1113/jphysiol.2006.
117069
Matsumoto, N., Minamimoto, T., Graybiel, A. M., and Kimura, M. (2001).
Neurons in the thalamic CM-Pf complex supply striatal neurons with
information about behaviorally significant sensory events. J. Neurophysiol. 85,
960–976. doi: 10.1152/jn.2001.85.2.960
Mena-Segovia, J., Winn, P., and Bolam, J. P. (2008). Cholinergic modulation of
midbrain dopaminergic systems. Brain Res. Rev. 58, 265–271. doi: 10.1016/j.
brainresrev.2008.02.003
Menegas, W., Bergan, J. F., Ogawa, S. K., Isogai, Y., Umadevi Venkataraju, K.,
Osten, P., et al. (2015). Dopamine neurons projecting to the posterior striatum
form an anatomically distinct subclass. Elife 4:e10032. doi: 10.7554/eLife.
10032
Morris, G., Arkadir, D., Nevet, A., Vaadia, E., and Bergman, H. (2004). Coincident
but distinct messages of midbrain dopamine and striatal tonically active
neurons. Neuron 43, 133–143. doi: 10.1016/j.neuron.2004.06.012
Nakano, I., and Hirano, A. (1984). Parkinson’s disease: neuron loss in the nucleus
basalis without concomitant Alzheimer’s disease. Ann. Neurol. 15, 415–418.
doi: 10.1002/ana.410150503
Frontiers in Neural Circuits | www.frontiersin.org 12 December 2017 | Volume 11 | Article 110
Rizzi and Tan Neuromodulatory Circuitry in PD
Narushima, M., Uchigashima, M., Fukaya, M., Matsui, M., Manabe, T.,
Hashimoto, K., et al. (2007). Tonic enhancement of endocannabinoid-
mediated retrograde suppression of inhibition by cholinergic interneuron
activity in the striatum. J. Neurosci. 27, 496–506. doi: 10.1523/jneurosci.4644-
06.2007
National Institute on Aging. (2011). Global Health and Aging. Bethesda, MD:
National Institute on Aging. (NIH Publication no: 11–7737)
Nelson, A. B., Hammack, N., Yang, C. F., Shah, N. M., Seal, R. P., and
Kreitzer, A. C. (2014). Striatal cholinergic interneurons drive GABA release
from dopamine terminals. Neuron 82, 63–70. doi: 10.1016/j.neuron.2014.
01.023
Neuhoff, H., Neu, A., Liss, B., and Roeper, J. (2002). I(h) channels contribute to
the different functional properties of identified dopaminergic subpopulations
in the midbrain. J. Neurosci. 22, 1290–1302.
Nicola, S. M., Surmeier, J., and Malenka, R. C. (2000). Dopaminergic modulation
of neuronal excitability in the striatum and nucleus accumbens. Annu. Rev.
Neurosci. 23, 185–215. doi: 10.1146/annurev.neuro.23.1.185
Ogawa, S. K., Cohen, J. Y., Hwang, D., Uchida, N., and Watabe-Uchida, M.
(2014). Organization of monosynaptic inputs to the serotonin and dopamine
neuromodulatory systems. Cell Rep. 8, 1105–1118. doi: 10.1016/j.celrep.2014.
06.042
Pacheco-Cano, M. T., Bargas, J., Hernández-López, S., Tapia, D., and Galarraga, E.
(1996). Inhibitory action of dopamine involves a subthreshold Cs+-
sensitive conductance in neostriatal neurons. Exp. Brain Res. 110, 205–211.
doi: 10.1007/bf00228552
Pan, P.-Y., and Ryan, T. A. (2012). Calbindin controls release probability in ventral
tegmental area dopamine neurons. Nat. Neurosci. 15, 813–815. doi: 10.1038/
nn.3099
Pascoli, V., Terrier, J., Hiver, A., and Lüscher, C. (2015). Sufficiency of mesolimbic
dopamine neuron stimulation for the progression to addiction. Neuron 88,
1054–1066. doi: 10.1016/j.neuron.2015.10.017
Pecho-Vrieseling, E., Rieker, C., Fuchs, S., Bleckmann, D., Esposito, M. S.,
Botta, P., et al. (2014). Transneuronal propagation of mutant huntingtin
contributes to non-cell autonomous pathology in neurons. Nat. Neurosci. 17,
1064–1072. doi: 10.1038/nn.3761
Perry, E. K., Curtis, M., Dick, D. J., Candy, J. M., Atack, J. R., Bloxham, C. A.,
et al. (1985). Cholinergic correlates of cognitive impairment in Parkinson’s
disease: comparisons with Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry
48, 413–421. doi: 10.1136/jnnp.48.5.413
Pisani, A., Centonze, D., Bernardi, G., and Calabresi, P. (2005). Striatal synaptic
plasticity: implications for motor learning and Parkinson’s disease. Mov.
Disord. 20, 395–402. doi: 10.1002/mds.20394
Prensa, L., and Parent, A. (2001). The nigrostriatal pathway in the rat: a
single-axon study of the relationship between dorsal and ventral tier nigral
neurons and the striosome/matrix striatal compartments. J. Neurosci. 21,
7247–7260.
Raz, A., Feingold, A., Zelanskaya, V., Vaadia, E., and Bergman, H. (1996).
Neuronal synchronization of tonically active neurons in the striatum of normal
and parkinsonian primates. J. Neurophysiol. 76, 2083–2088.
Reyes, S., Cottam, V., Kirik, D., Double, K. L., and Halliday, G. M. (2013).
Variability in neuronal expression of dopamine receptors and transporters
in the substantia nigra. Mov. Disord. 28, 1351–1359. doi: 10.1002/mds.
25493
Reynolds, J. N. J., and Wickens, J. R. (2004). The corticostriatal input to giant
aspiny interneurons in the rat: a candidate pathway for synchronising the
response to reward-related cues. Brain Res. 1011, 115–128. doi: 10.1016/j.
brainres.2004.03.026
Rice, M. E., and Cragg, S. J. (2004). Nicotine amplifies reward-related
dopamine signals in striatum. Nat. Neurosci. 7, 583–584. doi: 10.1038/
nn1244
Robbins, T. W., and Everitt, B. J. (1996). Neurobehavioural mechanisms of
reward and motivation. Curr. Opin. Neurobiol. 6, 228–236. doi: 10.1016/s0959-
4388(96)80077-8
Rossi, M. A., Sukharnikova, T., Hayrapetyan, V. Y., Yang, L., and Yin, H. H. (2013).
Operant self-stimulation of dopamine neurons in the substantia nigra. PLoS
One 8:e65799. doi: 10.1371/journal.pone.0065799
Sanghera, M. K., Manaye, K. F., Liang, C. L., Lacopino, A. M., Bannon, M. J.,
and German, D. C. (1994). Low dopamine transporter mRNA levels
in midbrain regions containing calbindin. Neuroreport 5, 1641–1644.
doi: 10.1097/00001756-199408150-00025
Saunders, A., Huang, K. W., and Sabatini, B. L. (2016). Globus pallidus externus
neurons expressing parvalbumin interconnect the subthalamic nucleus and
striatal interneurons. PLoS One 11:e0149798. doi: 10.1371/journal.pone.
0149798
Saunders, A., Oldenburg, I. A., Berezovskii, V. K., Johnson, C. A., Kingery, N. D.,
Elliott, H. L., et al. (2015). A direct GABAergic output from the basal ganglia to
frontal cortex. Nature 521, 85–89. doi: 10.1038/nature14179
Schiemann, J., Schlaudraff, F., Klose, V., Bingmer, M., Seino, S., Magill, P. J.,
et al. (2012). K-ATP channels in dopamine substantia nigra neurons control
bursting and novelty-induced exploration. Nat. Neurosci. 15, 1272–1280.
doi: 10.1038/nn.3185
Schiffmann, S. N., Lledo, P. M., and Vincent, J. D. (1995). Dopamine D1 receptor
modulates the voltage-gated sodium current in rat striatal neurones through
a protein kinase A. J. Physiol. 483, 95–107. doi: 10.1113/jphysiol.1995.sp0
20570
Schirinzi, T., Madeo, G., Martella, G., Maltese, M., Picconi, B., Calabresi, P., et al.
(2016). Early synaptic dysfunction in Parkinson’s disease: insights from animal
models.Mov. Disord. 31, 802–813. doi: 10.1002/mds.26620
Schultz,W. (1986). Responses ofmidbrain dopamine neurons to behavioral trigger
stimuli in the monkey. J. Neurophysiol. 56, 1439–1461.
Schultz, W. (2017). Reward prediction error. Curr. Biol. 27, R369–R371.
doi: 10.1016/j.cub.2017.02.064
Schultz, W., Dayan, P., and Montague, P. R. (1997). A neural substrate of
prediction and reward. Science 275, 1593–1599. doi: 10.1126/science.275.53
06.1593
Shippenberg, T. S. (1991). Conditioned reinforcing effects of 8-hydroxy-2-
(di-N-propylamino) tetralin: involvement of 5-hydroxytryptamine 1A and
D1 dopamine receptors. Neurosci. Lett. 121, 136–138. doi: 10.1016/0304-
3940(91)90668-j
Smith, Y., Bennett, B. D., Bolam, J. P., Parent, A., and Sadikot, A. F. (1994).
Synaptic relationships between dopaminergic afferents and cortical or thalamic
input in the sensorimotor territory of the striatum in monkey. J. Comp. Neurol.
344, 1–19. doi: 10.1002/cne.903440102
Smith, Y., Bevan, M. D., Shink, E., and Bolam, J. P. (1998). Microcircuitry of the
direct and indirect pathways of the basal ganglia. Neuroscience 86, 353–387.
Smith, Y., and Kieval, J. Z. (2000). Anatomy of the dopamine system in the
basal ganglia. Trends Neurosci. 23, S28–S33. doi: 10.1016/s1471-1931(00)
00023-9
Stamatakis, A. M., Jennings, J. H., Ung, R. L., Blair, G. A., Weinberg, R. J.,
Neve, R. L., et al. (2013). A unique population of ventral tegmental area neurons
inhibits the lateral habenula to promote reward. Neuron 80, 1039–1053.
doi: 10.1016/j.neuron.2013.08.023
Stamatakis, A. M., and Stuber, G. D. (2012). Activation of lateral habenula inputs
to the ventral midbrain promotes behavioral avoidance. Nat. Neurosci. 15,
1105–1107. doi: 10.1038/nn.3145
Stephenson-Jones, M., Yu, K., Ahrens, S., Tucciarone, J. M., van Huijstee, A. N.,
Mejia, L. A., et al. (2016). A basal ganglia circuit for evaluating action outcomes.
Nature 539, 289–293. doi: 10.1038/nature19845
Straub, C., Tritsch, N. X., Hagan, N. A., Gu, C., and Sabatini, B. L. (2014).
Multiphasic modulation of cholinergic interneurons by nigrostriatal afferents.
J. Neurosci. 34, 8557–8569. doi: 10.1523/JNEUROSCI.0589-14.2014
Stuber, G. D., Hnasko, T. S., Britt, J. P., Edwards, R. H., and Bonci, A. (2010).
Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum
corelease glutamate. J. Neurosci. 30, 8229–8233. doi: 10.1523/JNEUROSCI.
1754-10.2010
Sulzer, D., Joyce, M. P., Lin, L., Geldwert, D., Haber, S. N., Hattori, T., et al.
(1998). Dopamine neurons make glutamatergic synapses in vitro. J. Neurosci.
18, 4588–4602.
Sun, J., Xu, J., Cairns, N. J., Perlmutter, J. S., and Mach, R. H. (2012). Dopamine
D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2)
and dopamine transporter (DAT) densities in aged human brain. PLoS One
7:e49483. doi: 10.1371/journal.pone.0049483
Surmeier, D. J., Ding, J., Day, M., Wang, Z., and Shen, W. (2007). D1 and
D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal
medium spiny neurons. Trends Neurosci. 30, 228–235. doi: 10.1016/j.tins.2007.
03.008
Frontiers in Neural Circuits | www.frontiersin.org 13 December 2017 | Volume 11 | Article 110
Rizzi and Tan Neuromodulatory Circuitry in PD
Surmeier, D. J., and Graybiel, A. M. (2012). A feud that wasn’t: acetylcholine
evokes dopamine release in the striatum.Neuron 75, 1–3. doi: 10.1016/j.neuron.
2012.06.028
Tan, K. R., Yvon, C., Turiault, M.,Mirzabekov, J. J., Doehner, J., Labouèbe, G., et al.
(2012). GABA neurons of the VTA drive conditioned place aversion. Neuron
73, 1173–1183. doi: 10.1016/j.neuron.2012.02.015
Tanner, C. M., and Aston, D. A. (2000). Epidemiology of Parkinson’s disease and
akinetic syndromes. Curr. Opin. Neurol. 13, 427–430. doi: 10.1097/00019052-
200008000-00010
Taverna, S., Ilijic, E., and Surmeier, D. J. (2008). Recurrent collateral connections
of striatal medium spiny neurons are disrupted in models of Parkinson’s
disease. J. Neurosci. 28, 5504–5512. doi: 10.1523/JNEUROSCI.5493-07.2008
Tecuapetla, F., Jin, X., Lima, S. Q., and Costa, R. M. (2016). Complementary
contributions of striatal projection pathways to action initiation and execution.
Cell 166, 703–715. doi: 10.1016/j.cell.2016.06.032
Tecuapetla, F., Koós, T., Tepper, J. M., Kabbani, N., and Yeckel, M. F.
(2009). Differential dopaminergic modulation of neostriatal synaptic
connections of striatopallidal axon collaterals. J. Neurosci. 29, 8977–8990.
doi: 10.1523/JNEUROSCI.6145-08.2009
Threlfell, S., Lalic, T., Platt, N. J., Jennings, K. A., Deisseroth, K., and Cragg, S. J.
(2012). Striatal dopamine release is triggered by synchronized activity in
cholinergic interneurons. Neuron 75, 58–64. doi: 10.1016/j.neuron.2012.04.038
Tritsch, N. X., Ding, J. B., and Sabatini, B. L. (2012). Dopaminergic neurons inhibit
striatal output through non-canonical release of GABA. Nature 490, 262–266.
doi: 10.1038/nature11466
Tritsch, N. X., Granger, A. J., and Sabatini, B. L. (2016). Mechanisms and functions
of GABA co-release. Nat. Rev. Neurosci. 17, 139–145. doi: 10.1038/nrn.20
15.21
Tsai, H.-C., Zhang, F., Adamantidis, A., Stuber, G. D., Bonci, A., de Lecea, L.,
et al. (2009). Phasic firing in dopaminergic neurons is sufficient for behavioral
conditioning. Science 324, 1080–1084. doi: 10.1126/science.1168878
van Laar, T., De Deyn, P. P., Aarsland, D., Barone, P., and Galvin, J. E. (2010).
Effects of cholinesterase inhibitors in Parkinson’s disease dementia: a review
of clinical data. CNS Neurosci. Ther. 17, 428–441. doi: 10.1111/j.1755-5949.
2010.00166.x
Van Spaendonck, K. P., Berger, H. J., Horstink, M. W., Buytenhuijs, E. L., and
Cools, A. R. (1993). Impaired cognitive shifting in parkinsonian patients
on anticholinergic therapy. Neuropsychologia 31, 407–411. doi: 10.1016/0028-
3932(93)90164-u
Veenvliet, J. V., and Smidt, M. P. (2014). Molecular mechanisms of dopaminergic
subset specification: fundamental aspects and clinical perspectives. Cell. Mol.
Life Sci. 71, 4703–4727. doi: 10.1007/s00018-014-1681-5
Vitek, J. L., Bakay, R. A. E., Freeman, A., Evatt, M., Green, J., McDonald, W., et al.
(2003). Randomized trial of pallidotomy versusmedical therapy for Parkinson’s
disease. Ann. Neurol. 53, 558–569. doi: 10.1002/ana.10517
Wada, E., Wada, K., Boulter, J., Deneris, E., Heinemann, S., Patrick, J., et al. (1989).
Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor
subunit mRNAs in the central nervous system: a hybridization histochemical
study in the rat. J. Comp. Neurol. 284, 314–335. doi: 10.1002/cne.9028
40212
Wallace, M. L., Saunders, A., Huang, K. W., Philson, A. C., Goldman, M.,
Macosko, E. Z., et al. (2017). Genetically distinct parallel pathways in the
entopeduncular nucleus for limbic and sensorimotor output of the basal
ganglia. Neuron 94, 138.e5–152.e5. doi: 10.1016/j.neuron.2017.03.017
Wallén-Mackenzie, A., Wootz, H., and Englund, H. (2010). Genetic inactivation
of the vesicular glutamate transporter 2 (VGLUT2) in the mouse: what have we
learnt about functional glutamatergic neurotransmission?Ups. J. Med. Sci. 115,
11–20. doi: 10.3109/03009730903572073
Watabe-Uchida, M., Eshel, N., and Uchida, N. (2017). Neural circuitry of reward
prediction error. Annu. Rev. Neurosci. 40, 373–394. doi: 10.1146/annurev-
neuro-072116-031109
Watabe-Uchida, M., Zhu, L., Ogawa, S. K., Vamanrao, A., and Uchida, N. (2012).
Whole-brain mapping of direct inputs to midbrain dopamine neurons.Neuron
74, 858–873. doi: 10.1016/j.neuron.2012.03.017
Whissell, P. D., Tohyama, S., and Martin, L. J. (2016). The use of DREADDs to
deconstruct behavior. Front. Genet. 7:70. doi: 10.3389/fgene.2016.00070
Wieland, S., Du, D., Oswald, M. J., Parlato, R., Köhr, G., and Kelsch, W. (2014).
Phasic dopaminergic activity exerts fast control of cholinergic interneuron
firing via sequential NMDA, D2, and D1 receptor activation. J. Neurosci. 34,
11549–11559. doi: 10.1523/JNEUROSCI.1175-14.2014
Wilson, C. J., and Goldberg, J. A. (2006). Origin of the slow afterhyperpolarization
and slow rhythmic bursting in striatal cholinergic interneurons.
J. Neurophysiol. 95, 196–204. doi: 10.1152/jn.00630.2005
Wise, R. A. (2009). Roles for nigrostriatal—not just mesocorticolimbic—dopamine
in reward and addiction. Trends Neurosci. 32, 517–524. doi: 10.1016/j.tins.2009.
06.004
Witten, I. B., Steinberg, E. E., Lee, S. Y., Davidson, T. J., Zalocusky, K. A.,
Brodsky, M., et al. (2011). Recombinase-driver rat lines: tools, techniques,
and optogenetic application to dopamine-mediated reinforcement. Neuron 72,
721–733. doi: 10.1016/j.neuron.2011.10.028
Wolters, E. C., and Francot, C. M. (1998). Mental dysfunction in Parkinson’s
disease. Parkinsonism Relat. Disord. 4, 107–112. doi: 10.1016/S1353-
8020(98)00022-4
Woolf, N. J., and Butcher, L. L. (1986). Cholinergic systems in the rat brain:
III. Projections from the pontomesencephalic tegmentum to the thalamus,
tectum, basal ganglia, and basal forebrain. Brain Res. Bull. 16, 603–637.
doi: 10.1016/0361-9230(86)90134-6
Yao, W.-D., Spealman, R. D., and Zhang, J. (2008). Dopaminergic signaling in
dendritic spines. Biochem. Pharmacol. 75, 2055–2069. doi: 10.1016/j.bcp.2008.
01.018
Yin, H. H., and Knowlton, B. J. (2006). The role of the basal ganglia in habit
formation. Nat. Rev. Neurosci. 7, 464–476. doi: 10.1038/nrn1919
Zhang, H., and Sulzer, D. (2004). Frequency-dependent modulation of dopamine
release by nicotine. Nat. Neurosci. 7, 581–582. doi: 10.1038/nn1243
Zoli, M., Moretti, M., Zanardi, A., McIntosh, J. M., Clementi, F., and
Gotti, C. (2002). Identification of the nicotinic receptor subtypes expressed on
dopaminergic terminals in the rat striatum. J. Neurosci. 22, 8785–8789.
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Rizzi and Tan. This is an open-access article distributed under the
terms of the Creative Commons Attribution License (CC BY). The use, distribution
or reproduction in other forums is permitted, provided the original author(s) or
licensor are credited and that the original publication in this journal is cited, in
accordance with accepted academic practice. No use, distribution or reproduction
is permitted which does not comply with these terms.
Frontiers in Neural Circuits | www.frontiersin.org 14 December 2017 | Volume 11 | Article 110
